Syngene International Share Price
395.35-5.45 (-1.36%)
-39.35% past 1 Year
News
Goldman Sachs maintains Accumulate on Syngene with Rs 450 target price
Equity
SYNGENE
Syngene International to host analyst and investor meet on August 31
Equity
SYNGENE
Syngene says Bayview Facility will remain uncapitalized in FY27
Equity
SYNGENE
Syngene International expects margin improvement from H2 FY27 revenue and cost controls
Equity
SYNGENE
Syngene International guides for profitable, sustainable growth from FY28 onwards
Equity
SYNGENE
Syngene International revises FY27 guidance after Zoetis offtake halt, client attrition
Equity
SYNGENE
Syngene International guides single-digit FY27 revenue decline, margins mid-20s
Equity
SYNGENE
Syngene guides FY27 mid-20 percent EBITDA margin on cost optimisation focus
Equity
SYNGENE
Syngene International to double down on CDMO business in FY27
Equity
SYNGENE
Macquarie maintains Outperform on Syngene, sees H2FY27 business recovery
Equity
SYNGENE
Syngene International reports exceptional item of Rs 13.50 crores in results
Equity
SYNGENE
Syngene International Q1 FY earnings show sharp EBITDA and margin decline YoY
Equity
SYNGENE
Syngene International reports sharp year-on-year revenue decline in Q1 results
Equity
SYNGENE
Syngene International posts Q1 net loss versus prior year profit, earnings miss
Equity
SYNGENE
Syngene International to host Q1 earnings call on July 30 at 9 am
Equity
SYNGENE
Syngene promoter Kiran Mazumdar-Shaw signals confidence in business turnaround outlook
Equity
SYNGENE
Syngene International appoints Siddharth Mittal as new MD and CEO
Equity
SYNGENE
Syngene International informs about newspaper advertisements
Equity
SYNGENE
Syngene Internation. - Quaterly Results
Equity
SYNGENE
Syngene Internation. reports Profit after tax of 148.20 Crores, in the March 2026 quarter
Equity
SYNGENE